Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Dr. Kalyan Gaddam Announces The Results Of A Clinical Study For Relief For Patients With Cancer Cachexia
  • USA - English

Dr. Kalyan Gaddam, ND, a Board-certified Naturopathic Doctor, recently announced the release of the clinic study "Effect of free amino acids mix with medium triglycerides and Withania somnifera on cancer cachexia." The results are being released in conjunction with the annual meeting of the American Society of Clinical Oncology (ASCO) that begins May 31, 2019 in Chicago, IL.


News provided by

Dr. Kalyan Gaddam, ND

May 26, 2019, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Kalyan Gaddam, ND
Dr. Kalyan Gaddam, ND

PASO ROBLES, Calif., May 26, 2019 /PRNewswire-PRWeb/ -- Dr. Kalyan Gaddam, ND, a Board-certified Naturopathic Doctor, recently announced the release of the clinic study "Effects of free amino acids mix with medium triglycerides and Withania somnifera on cancer cachexia." The results are being released in conjunction with the annual meeting of the American Society of Clinical Oncology (ASCO) that begins May 31, 2019 in Chicago, IL.

Dr. Gaddam, ND has dedicated his professional life to education and research and creating a healing environment for his patients. The research projects he has participated in have led to results that help strengthen the body's natural healing ability. The research team led by him conducted clinical trials evaluating the benefits of E2 Energy nutritional powder that was consumed by cancer patients with cachexia. Dr. Gaddam, ND led the earlier research that developed E2 Energy.

He participated in a Q&A session with the staff from the Paso Robles Daily News to talk about this groundbreaking study.

Q: What is cancer cachexia and why is this study so important?

A: Cancer cachexia, also known as wasting syndrome, causes weight loss, weakness, low energy, muscle loss, anemia and anorexia. It is also common to other diseases such as HIV, chronic renal failure and multiple sclerosis. Our study focused on the benefits to cancer patients.

Q: How does the nutritional powder differ from other cachexia treatments?

A: Traditional nutritional support has not been successful in cancer cachexia. Most of the commercially available products have shown little to no effect.

The ingredients, in the nutritional powder, branched-chain amino acids, medium chain triglycerides, or MCTs, plus the herb Withania somnifera, all help build muscle and strength in addition to other benefits. It is also shown to improve fatigue in cancer patients

Q: What were the results of the trial?

A: We found that 14 patients had an overall improvement in the Piper Fatigue Score, 12 increased muscle mass and six patients either maintained or gained weight.

Q: What's the next step now that the results are in?

A: We are certainly encouraged and are now working on re-branding E2 Energy to release it commercially. It's been my goal to make it available for everyone since first formulating E2 Energy.

Q: What led you to this project?

A: I've always had a strong desire to help people live better and healthier. My medical career has always included research, looking for better solutions. Along with my ongoing oncology research into weight loss in cancer patients, I have led research teams that have developed natural nutritional products for Ayush Herbs and YouVeda, LLC. My research at Ayush Herbs contributed to the company's formulation of nutraceuticals for their products. I currently sit on the Board of Directors for YouVeda and am a co-formulator for their products, as well.

This early research put me in a good position to work as the principal investigator in this most recent clinical trial at the Comprehensive Blood and Cancer Center where I work in Bakersfield.

Q: What are your other areas of practice besides oncology?

A: I'm fortunate to have a comprehensive breadth of practice to call upon, but if I have to narrow it down, I would say non-opioid pain management and focusing on nutritional and natural ways to overcome pain and illness.

Q: How do you treat for pain without using opioids?

A: I use a number of treatments, including prolotherapy or peri-neural injections, platelet-rich plasma therapy, interferential, galvanic current, ultrasound, and Cold laser. For patients already using opioids or narcotics, I also use safe, natural alternatives to get them off these drugs. Pain management includes mind-body support through meditation, breathing exercises and yoga, too.

Q: What kinds of nutritional protocols do you recommend for your patients?

A: Good, basic nutrition is always recommended and I have recently started a personalized wellness diet plan as a joint venture with the Wellness Café in Bakersfield. This is the only program of its kind in Kern County, and benefits so many who are dealing with debilitating and life-threatening diseases including cancer, diabetes, celiac, inflammatory bowel diseases like Crohn's disease, ulcerative colitis and many more. When a patient comes to me, I create a customized nutritional program, and the Wellness Café prepares the food based on the menu I provide them.

About Dr. Kalyan Gaddam, ND:

He is a Board-certified Naturopathic Doctor. Gaddam provides services in Naturopathic Medicine, Homeopathy, Physical Medicine, Pain Management, Oncology, and Environmental medicine at the Comprehensive Blood and Cancer Center (CBCC) in Bakersfield CA, Salus Integrative Medicine in Paso Robles CA, and at the Premier Medical Group, Bakersfield CA.

The CBCC is the first cancer center in the San Joaquin Valley to earn The American College of Surgeons National Accreditation Program for Breast Centers (NAPBC) accreditation.

Gaddam studied Naturopathic Medicine at both Bharatividyapeeth University Hospital in India and Bastyr University, Washington, where he also served as a Resident Physician at Ayurvedic and Naturopathic Medical Clinic. He is the only naturopathic provider in Central California certified in Biofeedback and lymphedema management.

Gaddam is a member of the American Association of Naturopathic Physicians, Oncology Association of Naturopathic Physicians and California Naturopathic Doctors Association.

Kalyan R. Gaddam, ND
Bakersfield, CA
(661) 322-2206

SOURCE Dr. Kalyan Gaddam, ND

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.